Perinatal exposure to maternal lamotrigine: Clinical considerations for the mother and child

Canadian Family Physician

Volumn 56, Issue 11, 2010, Pages 1132-1134

  Madadi, Parvaz ^a   Ito, Shinya ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE;

BLURRED VISION; BREAST FEEDING; BREAST MILK; COMA; DIPLOPIA; DIZZINESS; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG MILK LEVEL; DYSPNEA; HUMAN; LACTATION; NAUSEA; NEWBORN; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PUERPERIUM; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR;

ADULT; ANTICONVULSANTS; BREAST FEEDING; EPILEPSY; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MATERNAL EXPOSURE; MILK, HUMAN; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TRIAZINES;

EID: 78649389702     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. EURAP Study Group. Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry. Epilepsia 2009;50(10):2305-9. Epub 2009 May 12.
2. Shor S, Koren G, Nulman I. Teratogenicity of lamotrigine. Can Fam Physician 2007;53:1007-9. Available from: www.cfp.ca/cgi/reprint/53/6/1007. Accessed 2010 Oct 1.
3. Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008;71(10):714-22. Epub 2008 Jul 23.
4. Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 2004;5(1):102-5.
5. Nordmo E, Aronsen L, Wasland K, Småbrekke L, Vorren S. Severe apnea in an infant exposed to lamotrigine in breast milk. Ann Pharmacother 2009;43(11):1893-7. Epub 2009 Oct 13.
6. Fotopoulou C, Kretz R, Bauer S, Schefold JC, Schmitz B, Dudenhausen JW, et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res 2009;85(1):60-4. Epub 2009 Mar 9.
7. Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 2004;62(2):292-5. Erratum in: Neurology 2010;74(24):2028.
8. Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008;70(22 Pt 2):2130-6. Epub 2007 Nov 28.
9. Newport DJ, Pennell PB, Calamaras MR, Ritchie JC, Newman M, Knight B, et al. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics 2008;122(1):e223-31. Epub 2008 Jun 30.
10. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000;41(6):709-13.
11. Gentile S. Lamotrigine in pregnancy and lactation. Arch Women Ment Health 2005;8(1):57-8. Epub 2005 May 4.
12. Page-Sharp M, Kristensen JH, Hackett LP, Beran RG, Rampono J, Hale TW, et al. Transfer of lamotrigine into breast milk. Ann Pharmacother 2006;40(7-8):1470-1.
13. Rambeck B, Kurlemann G, Stodiek SR, May TW, Jürgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51(6):481-4.
14. Tomson T, Ohman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38(9):1039-41. (Pubitemid 27382944)
15. Lofton AL, Klein-Schwartz W. Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother 2004;38(11):1811-5. Epub 2004 Sep 7.
16. De Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet 1999;36(6):439-52.
17. Cohen AF, Land GS, Breimer DD, Yuen WC, Winton C, Peck AW. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin Pharmacol Ther 1987;42(5):535-41.
18. Sabers A, Tomson T. Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol 2009;22(2):157-61.
19. Ehmer U, Vogel A, Schütte JK, Krone B, Manns MP, Strassburg CP. Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 2004;39(4):970-7. (Pubitemid 38428936)
20. Saeki M, Saito Y, Jinno H, Sai K, Hachisuka A, Kaniwa N, et al. Genetic variations and haplotypes of UGT1A4 in a Japanese population. Drug Metab Pharmacokinet 2005;20(2):144-51.
21. Blanca Sánchez M, Herranz JL, Leno C, Arteaga R, Oterino A, Valdizán EM, et al. UGT2B7--161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study. Ther Drug Monit 2010;32(2):177-84.